main content start

MedEnrich | Página principal

Continue Watching

últimos vidéos

últimos vidéos

Brightcove Home Latest Listing

Cáncer de mama

Cáncer de mama

Brightcove Cards Listing

Cáncer de próstata

Brightcove Cards Listing

Mieloma múltiple

Mieloma múltiple

Brightcove Cards Listing

Popular en MedEnrich

Popular in Sin nombre
  • Myelodysplastic Syndromes31m 24s

    Improving Diagnosis of MDS -Innovative Solutions

    Modern Web -Based digital tools based on 10 routinely used clinical parameters and Gradient Based Model can help in non-invasive diagnosis of MDS.
    mds diagnosis web based diagnosis her2negative mbc
  • Cancer de prostata6m 1s

    Androgen Receptor Targeted Therapies in patients with Cardiovascular Co Morbidities

    Referring the patients to cardiologist is an important aspect of managing patients with cardiovascular co-morbidities.
    hypertension cardiac events cardiovascular co-morbidities
  • Mieloma múltiple3m 12s

    Tips for Optimising Long Term Lenalidomide Maintenance in Multiple Myeloma

    Dr. Joseph Mikhael explains the triad of maintaining the patients on term Lenalidomide maintenance.
    long term maintenance therapy lenalidomide tips
  • Cáncer de mama3m 56s

    Duration of trastuzumab in patients with Her2 positive Metastatic Breast Cancer in prolonged remission

    There are no randomized clinical trials addressing the continued use of Trastuzumab for Her2 positive MBC patients in prolonged remission and has become important and relevant clinical question.
    her2 positive mbc prolonged remission trastuzumab duration
  • Mieloma múltiple8m 23s

    Treatment of High Risk Myeloma Patients

    While treating high risk patients it is critical to address complex biology & maximize the response for individual patients by gaining depth of response & maintaining that response for long duration. To ensure good quality of life patients should hav
    high risk myeloma
  • Mieloma múltiple4m 12s

    Key Practice Points -Myeloma Related Renal Impairment

    In patients with renal impairment primary goal is improvement of Renal Function which is associated with improved treatment outcomes. 50% of patients present renal impairment and renal impairment is severe in 15% of patients.
    myeloma renal impairment key practice points
  • Myelodysplastic Syndromes7m 3s

    Clinical Application of Web Based Tool for Improving MDS Diagnosis

    Gradient Based Model based on 10 routinely used parameters (Age, Gender, Hb, WBC, MCV, Platelets, Neutrophils, Monocytes, Glucose, Creatinine) is now available to facilitate non-invasive diagnosis of MDS.
    mds non-invasive diagnosis
  • Mieloma múltiple7m 22s

    Using Bone Targeted Therapy in Special Situations in Multiple Myeloma

    Bone targeting agents have different toxicities and rare complications which are dependent on the exposure to the specific treatment. Watch detailed video on MedEnrich on use of bone targeted agent in Multiple Myeloma
    bisphosphonates renal insufficiency hypercalcemia
  • Mieloma múltiple10m 40s

    Recommendations -Management of Myeloma Related Renal Impairment

    Supportive Care, Mechanical Approach and Systemic Antimyeloma treatment are 3 pillars of management of Myeloma related renal impairment. In supportive care prompt initiation of high fluid administration, appropriate use of Bisphosphonates can help.
    myeloma renal impairment lancet guidelines
  • Mieloma múltiple10m 19s

    CAR -T cells in Lymphoma

    CAR-T cell therapies are approved for treatment of Diffuse Large B Cell Lymphoma (DLBCL) , Follicular Lymphoma & Mantle Cell Lymphoma.
    car-t cell therapy high risk lymphoma
  • Seminarios web anteriores

    Seminarios web anteriores

    Webinar Cards Listing

    Artículos

    Artículos

    Medbytes Cards Listing
    Hi, can I help?
    Chat de ayudaX
    Equipo de soporte
    ¡Hola! ¿Cómo puedo ayudarlo/a hoy?
    Por favor seleccione alguna de las siguientes opciones.

    Buscar información

    Problemas con el inicio de sesión o registro

    Compartir un comentario